A biopharmaceutical company focused on developing innovative RNA-based therapeutics. Our goal is to harness the power of cutting-edge technology to improve the lives of people affected by serious and life-threatening diseases.

Private Funding Events

DateOfferedSoldType
2008-04-02UnknownUnknownOther (Paper Filing)